[Billing Code: 4140-01-P]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby
given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract
proposals and the discussions could disclose confidential trade secrets or commercial property
such as patentable material, and personal information concerning individuals associated with the
grant applications and/or contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel GMP Synthesis
of Bulk Drug Testing
Date: July 18, 2024
Time: 2:00 PM to 4:00 PM
Agenda: To review and evaluate contract proposals
Place: National Institute of Health
National Institute on Drug Abuse
301 North Stonestreet Avenue
Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Meysam Yazdankhah, Ph.D.
Scientific Review Officer
Scientific Review Branch
National Institute on Drug Abuse, NIH
301 North Stonestreet Avenue, MSC 6021
Bethesda, MD 20892
(301) 402-6965
meysam.yazdankhah@nih.gov
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel NIDA-L
Conflict SEP
Date: July 23, 2024
Time: 2:00 PM to 3:30 PM
Agenda: To review and evaluate grant applications

Place: National Institute of Health
National Institute on Drug Abuse
301 North Stonestreet Avenue
Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Sudhirkumar U. Yanpallewar, M.D.
Scientific Review Officer
Scientific Review Branch
National Institute on Drug Abuse, NIH
301 North Stonestreet Avenue, MSC 6021
Bethesda, MD 20892
(301) 443-4577
sudhirkumar.yanpallewar@nih.gov

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for Research Training; 93.279,
Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: June 17, 2024.
Lauren A. Fleck,
Program Analyst,
Office of Federal Advisory Committee Policy.
[FR Doc. 2024-13709 Filed: 6/21/2024 8:45 am; Publication Date: 6/24/2024]